Skip to content

Clinical trials

Phase 2 Gastrointestinal Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 2 Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20181
20192
20225
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Unknown status6
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Fudan University1
Harbin Medical University1
Jiangxi Provincial Cancer Hospital1
Nanjing First Hospital, Nanjing Medical University1
Peking University Cancer Hospital & Institute1
Peking University People's Hospital1
RemeGen Co., Ltd.1
Shenzhen Hornetcorn Bio-technology Company, LTD1
Shenzhen People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms15
Digestive System Neoplasms6
Colorectal Neoplasms4
Gastrointestinal Diseases4
Digestive System Diseases3
Esophageal Neoplasms3
Neoplasms3
Stomach Neoplasms3
Breast Neoplasms2
Esophageal Squamous Cell Carcinoma2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.